About Dr. Shi Guoming (施国明)
Dr. Shi Guoming is a Professor and Chief Physician in the Department of Hepatic Surgery at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine — one of China's most prestigious academic medical centers. A nationally recognized authority in liver cancer surgery and liver transplantation, Dr. Shi has dedicated his career to the surgical management of hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, liver metastases, and end-stage liver disease. He is widely regarded as one of Shanghai's leading hepatic surgeons, combining high surgical volume with a rigorous multidisciplinary approach to complex liver disease.
Dr. Shi's practice integrates open and laparoscopic hepatectomy, liver transplantation, and locoregional therapies within a comprehensive hepatobiliary oncology program. His team at Ruijin Hospital collaborates closely with hepatologists, interventional radiologists, and oncologists to deliver individualized, evidence-based care for every patient.
Core Surgical Specializations
1. Liver Cancer Surgery (Hepatocellular Carcinoma & Cholangiocarcinoma)
Conditions Treated:
- Hepatocellular carcinoma (HCC) — early, intermediate, and advanced stages
- Intrahepatic cholangiocarcinoma (ICC)
- Combined hepatocellular-cholangiocarcinoma (cHCC-CCA)
- Recurrent HCC after prior resection or ablation
- HCC with portal vein tumor thrombus (PVTT)
Procedures Performed:
- Anatomic and non-anatomic hepatectomy (open and laparoscopic)
- Major hepatectomy (right/left hemihepatectomy, trisectionectomy)
- Repeat hepatectomy for recurrent HCC
- Hepatectomy with portal vein reconstruction
- Two-stage hepatectomy with portal vein embolization (PVE)
- ALPPS (Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy)
Clinical Volume & Outcomes:
- One of Ruijin Hospital's highest-volume liver surgeons
- Extensive experience with complex resections including major vascular involvement
- Outcomes benchmarked against leading international hepatic surgery centers
2. Liver Transplantation
Indications:
- End-stage liver disease (cirrhosis from HBV, HCV, alcohol, NASH)
- HCC within Milan or UCSF criteria (transplant oncology)
- Acute liver failure
- Metabolic liver diseases (Wilson's disease, hereditary hemochromatosis)
- Cholestatic liver disease (primary biliary cholangitis, PSC)
Procedures Performed:
- Deceased donor liver transplantation (DDLT)
- Living donor liver transplantation (LDLT) — right lobe and left lateral segment
- Split liver transplantation
- Retransplantation for graft failure
Post-Transplant Care:
- Immunosuppression management and protocol optimization
- Surveillance for HCC recurrence post-transplant
- Management of biliary and vascular complications
3. Liver Metastases Surgery
Conditions Treated:
- Colorectal liver metastases (CRLM) — synchronous and metachronous
- Neuroendocrine tumor (NET) liver metastases
- Gastric cancer liver metastases
- Breast cancer liver metastases (selected cases)
Procedures Performed:
- Simultaneous colorectal resection and hepatectomy
- Staged hepatectomy for bilobar metastases
- Repeat hepatectomy for recurrent metastases
- Combination of resection with intraoperative ablation (RFA/MWA)
4. Minimally Invasive Hepatic Surgery
Procedures Performed:
- Laparoscopic minor and major hepatectomy
- Robotic-assisted liver resection
- Laparoscopic radiofrequency ablation (RFA) and microwave ablation (MWA)
- Laparoscopic management of liver cysts and benign tumors
Surgical Philosophy:
- Minimally invasive approaches are prioritized where oncologically safe, reducing hospital stay, blood loss, and recovery time
- Intraoperative ultrasound used routinely to guide resection margins and detect occult lesions
- Fluorescence-guided surgery (ICG) employed for real-time tumor margin visualization
Academic Achievements & National Leadership
- Professor of Surgery, Shanghai Jiao Tong University School of Medicine
- Chief Physician, Department of Hepatic Surgery, Ruijin Hospital
- Member, Chinese Society of Surgery — Liver Surgery Group
- Member, Chinese Society of Organ Transplantation
- Principal investigator on multiple NSFC-funded research projects in HCC biology and surgical outcomes
- Author of over 100 peer-reviewed publications in Chinese and international surgical and oncology journals
- Invited speaker at major international liver surgery conferences (IHPBA, ILTS, APASL)
Why International Patients Choose Dr. Shi Guoming
- High-volume liver surgery expertise: Surgical outcomes in liver cancer are strongly volume-dependent. Dr. Shi's extensive case volume translates into lower complication rates and better oncological outcomes.
- Full spectrum of liver disease management: From early HCC resection to liver transplantation and management of metastatic disease, Dr. Shi offers a complete continuum of care under one roof.
- Minimally invasive options: Laparoscopic and robotic hepatectomy reduce hospital stay, blood loss, and recovery time — critical for international patients with travel considerations.
- MDT-driven oncology: Every liver cancer case is reviewed at Ruijin Hospital's multidisciplinary tumor board, integrating surgery, medical oncology, interventional radiology, and hepatology.
- Cost-effectiveness: World-class liver surgery and transplantation at a fraction of the cost compared to equivalent centers in the US, UK, or Australia.
Treatment Protocols & Patient Journey
Step 1: Pre-Consultation Review
CMCS Shanghai coordinates a review of all available imaging (CT, MRI, PET-CT), laboratory results (AFP, liver function, viral hepatitis serology), and pathology reports prior to your first appointment with Dr. Shi.
Step 2: In-Person Consultation at Ruijin Hospital
Your consultation includes a detailed clinical assessment, review of imaging with Dr. Shi, liver function evaluation (Child-Pugh, MELD score), and a discussion of surgical options, risks, and expected outcomes. CMCS provides full medical interpretation throughout.
Step 3: Multidisciplinary Tumor Board Review
All liver cancer cases are presented at Ruijin Hospital's hepatobiliary MDT meeting, attended by surgeons, hepatologists, oncologists, and interventional radiologists. A consensus treatment plan is formulated and communicated clearly to the patient.
Step 4: Pre-Operative Workup
CMCS coordinates all pre-operative investigations including volumetric CT for future liver remnant (FLR) assessment, cardiopulmonary evaluation, anesthesia review, and any required pre-operative interventions (portal vein embolization, bridging TACE).
Step 5: Surgery & Inpatient Care
CMCS provides on-site support during hospital admission, including daily check-ins, interpretation during ward rounds, and liaison with the nursing and surgical team. Typical inpatient stay for a major hepatectomy is 7–10 days.
Step 6: Post-Operative Follow-Up & Repatriation
CMCS coordinates discharge planning, post-operative imaging, pathology review, and oncology referral for adjuvant therapy where indicated. A full medical summary in English is prepared for your home country physicians.
Frequently Asked Questions
Can Dr. Shi see international patients without a Chinese referral letter?
Yes. CMCS Shanghai facilitates direct access to Dr. Shi's clinic at Ruijin Hospital for international patients. Prior imaging and laboratory results are helpful but a formal referral letter is not mandatory.
Is liver transplantation available for international patients at Ruijin Hospital?
Liver transplantation for international patients in China is subject to national regulations governing organ allocation. CMCS Shanghai can provide up-to-date guidance on eligibility and the process for international patients seeking transplant evaluation at Ruijin Hospital.
What is the typical recovery time after a laparoscopic liver resection?
Laparoscopic minor hepatectomy typically requires a hospital stay of 4–6 days, with full recovery in 3–4 weeks. Major laparoscopic hepatectomy may require 7–10 days inpatient, with recovery of 4–6 weeks. Open major hepatectomy typically requires 10–14 days inpatient and 6–8 weeks for full recovery.
What languages does Dr. Shi's team communicate in?
Dr. Shi's clinical team communicates primarily in Mandarin Chinese. CMCS Shanghai provides full English medical interpretation for all consultations, ward rounds, and discharge discussions.
How do I send my imaging and reports for a pre-consultation review?
Contact CMCS Shanghai via email at contract@medicalsh.com or WeChat (gezhanglao). We will provide secure upload instructions and coordinate the review with Dr. Shi's team within 3–5 business days.
Schedule Your Consultation
If you or a family member is facing a diagnosis of liver cancer, liver metastases, or end-stage liver disease and are seeking expert surgical care in Shanghai, CMCS Shanghai can arrange a consultation with Dr. Shi Guoming at Ruijin Hospital.
- 📧 Email: contract@medicalsh.com
- 💬 WeChat: gezhanglao
- 🌐 Website: medicalsh.com
CMCS Shanghai — Connecting international patients with China's top specialists, from first inquiry to full recovery.
Disclaimer: This profile is intended for educational and informational purposes only. CMCS Shanghai is a medical concierge service and does not provide direct medical care. All clinical decisions are made by licensed physicians at accredited hospitals.
0 comentarios